重度哮喘BAL细胞基因表达揭示重症机制及药物影响
研究对154例哮喘及对照受试者的BAL细胞进行基因表达谱分析,其中100例有配套气道上皮细胞基因表达数据。分析显示年龄、性别、种族、细胞比例和药物显著影响BAL细胞基因表达,富集cAMP信号组分的表达网络最能区分重度哮喘。体外模型提示β激动剂暴露可快速上调cAMP相关表达,且BAL裂解物ELISA显示蛋白水平可能与表达变化不完全一致。
要点
- 年龄、性别、种族、细胞比例和药物显著影响BAL细胞基因表达。
- 富集cAMP信号组分的BAL细胞表达网络最能区分重度哮喘。
- β激动剂暴露可能快速影响基因表达,蛋白水平与表达变化不一定一致。
核心结论
- BAL细胞基因表达受年龄、性别、种族、细胞比例和药物等因素影响,需仔细识别并校正。
- 富集cAMP信号组分的BAL细胞表达网络最能区分重度哮喘与其他受试者。
- β激动剂暴露可能强烈且即时影响细胞基因表达,未必反映重要疾病机制或匹配蛋白水平。
- 无偏系统分析发现的重度相关基因映射到哮喘易感位点,提示新靶点。
研究设计与样本
- 对154例哮喘和对照受试者的BAL细胞进行基因表达谱分析,其中100例有配套气道上皮细胞基因表达数据。
- 将BAL细胞表达谱与受试者特征(年龄、性别、种族、药物)和样本特征(细胞比例)关联。
- 通过关联转录本和共表达网络与肺功能、过去一年急诊就诊或住院、药物使用及生活质量评分确定严重度相关基因表达。
- 采用体外细胞模型验证cAMP相关表达现象。
- 对BAL裂解物进行ELISA检测蛋白水平。
主要发现
- 年龄、性别、种族、细胞比例和药物强烈影响BAL细胞基因表达。
- 富集cAMP信号组分的BAL细胞表达网络最能区分重度哮喘受试者。
- 体外模型显示非重度且未使用β激动剂的受试者在细胞采集前给予β激动剂后cAMP相关表达显著上调。
- BAL裂解物ELISA显示蛋白水平可能与表达变化部分不一致。
- 无偏系统分析发现的重度相关基因映射到哮喘易感位点。
关键数值与推荐
- BAL细胞表达谱分析纳入154例哮喘和对照受试者,其中100例有气道上皮细胞基因表达数据。
- 严重度相关分析关联肺功能、过去一年急诊就诊或住院、药物使用及生活质量评分。
- 体外模型显示非重度且未使用β激动剂的受试者在细胞采集前给予β激动剂后cAMP相关表达显著上调。
临床怎么用
- 解读BAL细胞基因表达时需考虑年龄、性别、种族、细胞比例和药物等影响因素。
- β激动剂暴露可能快速影响基因表达,判读表达数据时应关注采药时序。
- 蛋白水平与基因表达变化可能不一致,需结合蛋白检测综合评估。
- 重度哮喘相关基因映射到易感位点,可为靶点发现提供线索。
局限性
- BAL细胞基因表达受多种因素影响,需仔细识别和校正。
- 蛋白水平可能与基因表达变化不完全一致。
- 体外模型结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Gene expression of BAL cells, which samples the cellular milieu within the lower respiratory tract, has not been well studied in severe asthma.Objectives: To identify new biomolecular mechanisms underlying severe asthma by an unbiased, detailed interrogation of global gene expression.Methods: BAL cell expression was profiled in 154 asthma and control subjects. Of these participants, 100 had accompanying airway epithelial cell gene expression. BAL cell expression profiles were related to participant (age, sex, race, and medication) and sample traits (cell proportions), and then severity-related gene expression determined by correlating transcripts and coexpression networks to lung function, emergency department visits or hospitalizations in the last year, medication use, and quality-of-life scores.Measurements and Main Results: Age, sex, race, cell proportions, and medications strongly influenced BAL cell gene expression, but leading severity-related genes could be determined by carefully identifying and accounting for these influences. A BAL cell expression network enriched for cAMP signaling components most differentiated subjects with severe asthma from other subjects. Subsequently, an in vitro cellular model showed this phenomenon was likely caused by a robust upregulation in cAMP-related expression in nonsevere and β-agonist-naive subjects given a β-agonist before cell collection. Interestingly, ELISAs performed on BAL lysates showed protein levels may partly disagree with expression changes.Conclusions: Gene expression in BAL cells is influenced by factors seldomly considered. Notably, β-agonist exposure likely had a strong and immediate impact on cellular gene expression, which may not translate to important disease mechanisms or necessarily match protein levels. Leading severity-related genes were discovered in an unbiased, system-wide analysis, revealing new targets that map to asthma susceptibility loci.
引用
- Weathington N, O'Brien ME, Radder J, et al. BAL Cell Gene Expression in Severe Asthma Reveals Mechanisms of Severe Disease and Influences of Medications. Am J Respir Crit Care Med. 2019. PMID: 31161938. doi:10.1164/rccm.201811-2221OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。